Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 19/20 | 0.42 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24251363 | 0.82 | SPR (0.39) | — | |
| SCHEMBL24251381 | 0.82 | TNKS2 (0.32) | CHRM1 | |
| SCHEMBL24251616 | 0.81 | NPC1 (0.40) | — | |
| SCHEMBL24251473 | 0.81 | SCN9A (0.38) | — | |
| SCHEMBL24251398 | 0.81 | PBK (0.40) | — | |
| SCHEMBL24251451 | 0.81 | GUCY1B2 (0.45) | CNR1 | |
| SCHEMBL24251583 | 0.80 | PDE10A (0.44) | — | |
| SCHEMBL24251512 | 0.80 | TAS1R3 (0.43) | CNR1 | |
| SCHEMBL24251374 | 0.80 | TAS1R3 (0.49) | CNR1 | |
| SCHEMBL23355438 | 0.78 | PDE4B (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220048903-A1 | Anthelminthic Heterocyclic Compounds | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2022-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220048903-A1 | Anthelminthic Heterocyclic Compounds | SDHA, PAH, PIGS | CHRM1 2014/4885CNR1 904/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.